Current financial headlines

Sharemaestro Newsreel

Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.

Showing: 1–36
Headlines: 50
Sources here: 2
Companies here: 7

Current section Brazil Medical Devices news Latest headline 18:49, 13 August 2026

Latest18:49 · 13 August 2026

finance.yahoo.com Earnings

Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?

Stryker Corporation SYK entered the second half of 2026 with momentum restored after the March cybersecurity disruption. Second-quarter sales, earnings and margins improved as production recovered, while management narrowed its full-year outlook. The next test is execution. Stryker must keep normalizing production, convert elevated backlog into shipments and support a broad product launch cycle. Those factors will determine …

Main company 🇧🇷 Brazil

Read at finance.yahoo.com

Sharemaestro market context Price above Trend Line 52 weeks -15.8%

Just inNext headlines

18:49 13 Aug 2026

finance.yahoo.com Earnings Main company 🇧🇷 Brazil

Stryker Up 13.6% in 3 Months as Recovery Gains Strength, What's Next?

Stryker Corporation SYK shares have risen 13.6% in the past three months, outpacing the Zacks Medical sector's 12.9% gain and the S&P 500's 1.7% advance. The move has coincided with a sharper operating recovery after a difficult first quarter. The investor question is whether …

S1YK34 main company

Sharemaestro market context Price above Trend Line 52 weeks -15.8%

14:30 13 Aug 2026

finance.yahoo.com Analyst action Provider-linked mention 🇧🇷 Brazil

Wall Street Bulls Look Optimistic About Medtronic (MDT): Should You Buy?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Before …

MDTC34 mentioned

Sharemaestro market context Price below Trend Line 52 weeks -10.3%

Chronological news

Latest headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

13:51 13 Aug 2026

finance.yahoo.com Earnings Main company 🇧🇷 Brazil

Edwards Climbs 14% in 3 Months as Growth Strength Tests Valuation

Edwards Lifesciences Corporation EW shares have gained 14% in the past three months as growth across its structural-heart franchises has strengthened the operating case. Second-quarter results showed double-digit expansion in transcatheter aortic valve replacement and faster growth in transcatheter mitral and tricuspid therapies. The …

E1WL34 main company MDTC34 mentioned

Sharemaestro market context Trend signal active 52 weeks -0.3%

13:49 13 Aug 2026

finance.yahoo.com Earnings Main company 🇧🇷 Brazil

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

ABTT34 main company MDTC34 mentioned

Sharemaestro market context Price above Trend Line 52 weeks -21.9%

13:40 13 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇧🇷 Brazil

FitLife Brands Inc. (FTLF) Beats Q2 Earnings and Revenue Estimates

FitLife Brands Inc. (FTLF) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents …

MDTC34 mentioned

Sharemaestro market context Price below Trend Line 52 weeks -10.3%

13:37 13 Aug 2026

finance.yahoo.com Analyst action Main company 🇧🇷 Brazil

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …

S1YK34 main company

Sharemaestro market context Price above Trend Line 52 weeks -15.8%

13:30 13 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇧🇷 Brazil

Here's How Much You'd Have If You Invested $1000 in DexCom a Decade Ago

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries. The fear of missing out, or FOMO, also plays a factor in …

D1EX34 mentioned

Sharemaestro market context Trend signal active 52 weeks -0.9% · Next-week setup negative 37.9%

05:43 13 Aug 2026

finance.yahoo.com Market update Main company 🇧🇷 Brazil

Revisiting Former Stock Picks Medtronic, Quantas Services, Lennar

Reassessing stock picks is one of the best habits an investor can build. Watch Doug discuss recent stock picks, provide input on the current market environment—and take your questions. The daily chart illustrates how well the stock has performed relative to its peers on …

MDTC34 main company

Sharemaestro market context Price below Trend Line 52 weeks -10.3%

23:09 12 Aug 2026

finance.yahoo.com Earnings Main company 🇧🇷 Brazil

LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. LivaNova (LIVN) raised its full year 2026 revenue and earnings guidance after reporting record …

L2IV34 main company

Sharemaestro market context Stored weekly price path 4 weeks +3.9%

19:36 12 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇧🇷 Brazil

Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?

DexCom, Inc. DXCM is entering the second half of 2026 with healthier margins, broader reimbursement and a larger continuous glucose monitoring opportunity. The investment question is whether that improving setup is enough to justify a premium valuation. Growth catalysts remain visible across U.S. coverage, …

ABTT34 mentioned D1EX34 mentioned

Sharemaestro market context Price above Trend Line 52 weeks -21.9%

19:34 12 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇧🇷 Brazil

DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026?

DexCom DXCM stock has rebounded sharply in 2026, gaining 34.8% after falling 14.7% in 2025, as investors increasingly recognize the company's improving growth profile and expanding continuous glucose monitoring (CGM) opportunity. The company's share price performance so far this year has outperformed the industry's …

ABTT34 mentioned D1EX34 mentioned

Sharemaestro market context Price above Trend Line 52 weeks -21.9%

19:33 12 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇧🇷 Brazil

DXCM Rallies 52.5% in 3 Months. Can the Stock Keep Climbing From Here?

DexCom, Inc. DXCM shares have climbed 52.5% in the past three months, a sharp re-rating that raises the standard for further gains. The next leg depends less on momentum alone and more on whether earnings growth, margin expansion and new-market access can keep pace …

ABTT34 mentioned D1EX34 mentioned

Sharemaestro market context Price above Trend Line 52 weeks -21.9%

19:33 12 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇧🇷 Brazil

Can DexCom's Raised 2026 Outlook Sustain Stronger Margin Momentum?

DexCom, Inc. DXCM raised its 2026 revenue and margin outlook after a stronger second quarter, shifting more attention toward profitability. The question is whether better gross margin and operating leverage can persist as organic growth improves. The guidance increase is encouraging, but foreign exchange, …

ABTT34 mentioned D1EX34 mentioned

Sharemaestro market context Price above Trend Line 52 weeks -21.9%

18:30 12 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇧🇷 Brazil

[Latest] Global Whey Protein Market Size/Share Worth USD 26.04 Billion by 2034 at a 7.56% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Whey Protein Market size & share revenue was valued at approximately USD 12.58 Billion in 2024 and is expected to reach …

ABTT34 mentioned

Sharemaestro market context Price above Trend Line 52 weeks -21.9%

18:20 12 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇧🇷 Brazil

Two Years Of Growth Barely Change What You Pay For Intuitive Surgical

Photo by 127071 on Pixabay Consensus growth takes only a modest slice off the multiple, and the company has not yet set the instrument pricing that lands inside those two years. Intuitive Surgical (ISRG) trades at about $401.23, roughly 32% below its 52-week high …

MDTC34 mentioned

Sharemaestro market context Price below Trend Line 52 weeks -10.3%

16:34 12 Aug 2026

finance.yahoo.com Earnings Main company 🇧🇷 Brazil

LivaNova (LIVN) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Briana Gotlin Chief Executive Officer and member of the Board of Directors - Vladimir Makatsaria Chief Innovation Officer - Ahmet Tezel Chief …

L2IV34 main company

Sharemaestro market context Stored weekly price path 4 weeks +3.9%

14:14 12 Aug 2026

finance.yahoo.com Market update Main company 🇧🇷 Brazil

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national …

ABTT34 main company

Sharemaestro market context Price above Trend Line 52 weeks -21.9%

13:25 12 Aug 2026

finance.yahoo.com Analyst action Provider-linked mention 🇧🇷 Brazil

Oppenheimer Sees $500 for Intuitive Surgical as Rivals Stall

This article first appeared on GuruFocus. Intuitive Surgical (NASDAQ:ISRG) rose 0.90% premarket after Oppenheimer upgraded the robotic surgery company to Outperform from Perform with a $500 price target. The firm's case rests less on Intuitive than on its competitors: workflow integration problems for Johnson …

MDTC34 mentioned

Sharemaestro market context Price below Trend Line 52 weeks -10.3%

08:45 12 Aug 2026

nasdaq.com Earnings Provider-linked mention 🇧🇷 Brazil

Biotech Stocks At 52-Week Highs - ALMR +30% On Q2 Reports, DYN, CGEM, DXCM, CAH

(RTTNews) - The following biotech stocks reached a 52-week high on August 11, 2026, driven up by key catalysts such as positive quarterly or full year reports. Alamar Biosciences Inc. (ALMR) Alamar Biosciences is a proteomics company that has develops a liquid biopsy platform …

D1EX34 mentioned

Sharemaestro market context Trend signal active 52 weeks -0.9% · Next-week setup negative 37.9%

03:35 12 Aug 2026

finance.yahoo.com Earnings Main company 🇧🇷 Brazil

Does Medtronic (MDT) Still Trade At A Discount After Its CE Mark Win?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Medtronic stock has delivered a 20.8% gain over the past three years, yet current checks suggest it now sits close to its estimated …

MDTC34 main company

Sharemaestro market context Price below Trend Line 52 weeks -10.3%

22:23 11 Aug 2026

finance.yahoo.com Earnings Main company 🇧🇷 Brazil

Stryker’s (SYK) Comeback Quarter Looks Great, But At What Cost?

Stryker (NYSE:SYK) turned in one of its stronger quarters in recent memory on July 30, with sales climbing 9.4% to $6.6 billion and reported EPS jumping 44.1% to $3.30. The numbers arrive as the company works its way back from a cyber incident that …

S1YK34 main company

Sharemaestro market context Price above Trend Line 52 weeks -15.8%

21:31 11 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇧🇷 Brazil

Top Research Reports for Meta, Texas Instruments & CrowdStrike

Tuesday, August 11, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Meta Platforms, Inc. (META), Texas Instruments Inc. (TXN) and CrowdStrike Holdings, Inc. (CRWD), as well …

MDTC34 mentioned

Sharemaestro market context Price below Trend Line 52 weeks -10.3%

20:15 11 Aug 2026

finance.yahoo.com Earnings Main company 🇧🇷 Brazil

Medtronic (MDT) Wins Analyst Upgrades, Is It Fully Priced?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Medtronic (MDT) has moved back into focus after multiple analyst upgrades tied to what they describe as the company's strongest annual revenue growth …

MDTC34 main company

Sharemaestro market context Price below Trend Line 52 weeks -10.3%

18:41 11 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇧🇷 Brazil

Arrow Exploration confirms four zones at Icaco 3, opens up ~10 new drilling locations

Arrow Exploration Corp (TSX-V:AXL, AIM:AXL, OTC:CSTPF) CEO Marshall Abbott tells Proactive's Stephen Gunnion that the Icaco 3 well has confirmed up to four hydrocarbon-bearing zones in the Icaco extension of the Tapir Block in Colombia, opening almost 10 additional development locations across the Ubaque, …

ABTT34 mentioned

Sharemaestro market context Price above Trend Line 52 weeks -21.9%

14:09 11 Aug 2026

finance.yahoo.com Capital return Provider-linked mention 🇧🇷 Brazil

The Number One Reason I Keep Buying Intuitive Surgical Now For The Long Run

Quick Read ISRG is down 31% YTD, but its razor-and-razorblade model now delivers 85% recurring revenue across a fleet of 11,710 da Vinci systems. MDT's Hugo and JNJ's Ottava remain early or pre-commercial, leaving ISRG's $1.73 billion quarterly instruments-and-accessories stream with no real soft-tissue …

MDTC34 mentioned

Sharemaestro market context Price below Trend Line 52 weeks -10.3%

14:00 11 Aug 2026

finance.yahoo.com Market update Main company 🇧🇷 Brazil

Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI

Multi-year collaboration combines ongoing glucose insights from Abbott's Lingo biowearable with Google Health's technology to create a more comprehensive view of personal health Partnership includes a large-scale research study to better inform artificial intelligence (AI) coaching available in the Google Health app and future …

ABTT34 main company

Sharemaestro market context Price above Trend Line 52 weeks -21.9%

13:00 11 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇧🇷 Brazil

Versa Vascular Appoints Bill Shields as Chief Executive Officer

Company Expands Series C Financing to $42M SANTA CRUZ, Calif., August 11, 2026--(BUSINESS WIRE)--Versa Vascular, Inc., a pioneering medical device company dedicated to transforming tricuspid valve disease treatment, announced the appointment of Bill Shields as Chief Executive Officer. Former Versa CEO David Hovda is …

MDTC34 mentioned

Sharemaestro market context Price below Trend Line 52 weeks -10.3%

10:05 11 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇧🇷 Brazil

Pulsed Field Ablation Global Market Report 2026 Now Available - Profiles Boston Scientific, Medtronic, Biosense Webster, and 15 Other Players

Company Logo Pulsed Field Ablation MarketPulsed Field Ablation Market Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Pulsed Field Ablation Market by Therapeutic Area, Product Components, Application Area, Source of Ablation, Key Geographical Regions, and Sales Forecast of Leading Players - Trends and Forecast …

MDTC34 mentioned B1SX34 mentioned

Sharemaestro market context Price below Trend Line 52 weeks -10.3%

23:46 10 Aug 2026

finance.yahoo.com Market update Main company 🇧🇷 Brazil

Abbott vs. Medtronic: Is Consistent Growth Better Than a Turnaround Story?

Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both prominent names in the Medtech space. Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices businesses helped …

ABTT34 main company MDTC34 mentioned

Sharemaestro market context Price above Trend Line 52 weeks -21.9%

23:36 10 Aug 2026

finance.yahoo.com Earnings Provider-linked mention 🇧🇷 Brazil

Johnson & Johnson vs. Medtronic: Which Healthcare Stock Is Better Positioned After Earnings?

Johnson & Johnson (NYSE:JNJ) delivered another strong quarter in fiscal Q2 2026, with reported sales increasing 6.6% year over year to $25.31 billion and surpassing analysts' average estimate of around $25.05 billion. Adjusted earnings per share reached $2.90, also exceeding estimates of $2.85. The …

MDTC34 mentioned

Sharemaestro market context Price below Trend Line 52 weeks -10.3%

22:45 10 Aug 2026

finance.yahoo.com Earnings Main company 🇧🇷 Brazil

Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

In the latest close session, Medtronic (MDT) was up +2.58% at $89.41. The stock outperformed the S&P 500, which registered a daily loss of 0.06%. Elsewhere, the Dow lost 0.11%, while the tech-heavy Nasdaq lost 0.32%. The medical device company's stock has climbed by …

MDTC34 main company

Sharemaestro market context Price below Trend Line 52 weeks -10.3%

21:49 10 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇧🇷 Brazil

Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?

Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 ⁠billion, above analysts' average estimate of about $25.05 billion. Adjusted earnings per share reached $2.90, surpassing the expectation of $2.85. The company also raised …

ABTT34 mentioned

Sharemaestro market context Price above Trend Line 52 weeks -21.9%

21:12 10 Aug 2026

finance.yahoo.com Analyst action Provider-linked mention 🇧🇷 Brazil

Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates

Orchestra BioMed Holdings, Inc. The BACKBEAT global pivotal trial ("BACKBEAT Trial"), conducted in collaboration with Medtronic, is on track to reach its target of 284 evaluable randomized patients by end of Q3 2026, with primary data presentation targeted for Q2 2027, assuming those endpoints …

MDTC34 mentioned

Sharemaestro market context Price below Trend Line 52 weeks -10.3%

18:46 10 Aug 2026

finance.yahoo.com Earnings Main company 🇧🇷 Brazil

Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026?

Michael F. Mahoney, Chairman, President & CEO of Boston Scientific Corporation (NYSE:BSX), purchased 186,240 shares of common stock at $48.34 per share on August 3, 2026. SEC Form 4 filing. Transaction summary Metric Value Transaction value $10.1 million Shares purchased 208,359 Post-transaction shares (total) …

B1SX34 main company

Sharemaestro market context Price below Trend Line 52 weeks -54.9%

15:43 10 Aug 2026

finance.yahoo.com Market update Provider-linked mention 🇧🇷 Brazil

Should You Buy, Hold or Sell ABT Stock Amid Medical Devices Boom?

Abbott Laboratories' ABT Medical Devices remains its largest segment and continues to benefit from a strong pipeline of new product launches and growing adoption across cardiovascular care and diabetes management. The segment is well positioned to capitalize on the expanding global medical devices market. …

ABTT34 mentioned B1SX34 mentioned

Sharemaestro market context Price above Trend Line 52 weeks -21.9%